The results showed that the lower expression levels of ANXA1, HSP90B1, PSMA7, PRDX6, and PPP1CB are associated with better prognosis (ANXA1, p = 0.0022, HR = 1.6, p(HR) = 0.0023; HSP90B1, p = 0.031, HR = 1.4, p(HR) = 0.032; PSMA7, p = 0.015, HR = 1.5, p(HR) = 0.015; PRDX6, p = 0.0065, HR = 1.5, p(HR) = 0.0069; PPP1CB, p = 0.023, HR = 1.4, p(HR) = 0.023) (Figures 7A–E), while higher expression of VEGFA gene was linked to better prognosis of bladder cancer (VEGFA, p = 0.019, HR = 0.7, p(HR) = 0.02) (Figure 7F). This evidence concerns the gene HSP90B1 and urinary bladder carcinoma.